| Resumen congreso | 2024 | Factors associated with poor mental health in patients with axial spondyloarthritis. Results from the international map of axial spondyloarthritis (imas) | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 2024 | Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2024 | Regional differences in patient diagnosis journey and healthcare utilization. Results from the international map of axial spondyloarthritis (imas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2024 | The impact of axial spondyloarthritis on patients’ sexual life. Results from the international map of axial spondyloarthritis (imas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2024 | What factors are associated with pain intensity in axial spondyloarthritis? Results from the international map of axial spondyloarthritis (imas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2023 | Diagnostic delay in patients included in the international map of axial spondyloarthrtis: associations with geographic, socio-demographic and disease-related factors | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2023 | Females with axial spondyloarthritis report higher burden of disease and worse patient-reported outcomes. Results from the international map of axial spondyloarthritis (imas) | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 2023 | Instrument selection for the ASAS core outcome set for axial spondyloarthritis | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2023 | Regional differences in clinical phenotype of axial spondyloarthritis. Results from the international map of axial spondyloarthritis (imas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2023 | The disease burden of axspa: argentinian data from the international map of axial spondyloarthritis (IMAS) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2023 | The international map of axial spondyloarthritis (IMAS). Results from the perspective of 5,557 patients from 27 countries around the world | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2023 | The international map of axial spondyloarthritis global report: supporting the inclusion of the patient perspective in policy and clinical practice | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2023 | Which factors are associated with clinically high disease activity in axial spondyloarthritis? Results from the international map of axial spondyloarthritis (IMAS) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2022 | Adapting to living with axial spondyloarthritis. Results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2022 | Assessing healthcare utilization in patients with axial spondyloarthritis. results from the spanish atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2022 | Assessment of the impact of axial spondyloarthritis on patient's social life. Results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2022 | How fears and hopes have evolved in patients with rmds throughout the Covid-19 pandemic? Results from the reumavid study (phase 1 and 2) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2022 | Impact of the Covid-19 pandemic on healthcare utilizations of rmd patients in Europe. Results from the reumavid study (phase 1 and 2) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2022 | Tocilizumab in large-vessel giant cell arteritis and takayasu arteritis: multicentric observational comparative study | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2022 | Working from home in patients with rmds during the Covid-19 pandemic in Europe. Results from the reumavid study (phase 1 and 2) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Assessment of the Covid-19 pandemic from the perspective of people with rheumatic musculoskeletal diseases in europe. results from the reumavid study (phase 1) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Country comparison on the impact of the Covid-19 pandemic on patients with rheumatic diseases, Results from the reumavid study (phase 1) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Factors associated with engaging in physical activity in axial spondyloarthritis. Results from the european map of axial spondyloarthritis (EMAS) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Factors associated with inability to work and disability in patients with axial spondyloarthritis. Results from the european map of axial spondyloarthritis (EMAS) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Factors associated with pain intensity in axial spondyloarthritis. Results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Fears and hopes during the covid-19 pandemic in patients with rheumatic diseases. Results from the reumavid study (phase 1) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Gender differences on the impact of the covid-19 pandemic and lockdown in patients with rheumatic diseases. Results from the reumavid study (phase 1) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Health impact of overweight and obesity in patients with axial spondyloarthritis. Results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Impact of Covid-19 pandemic in overall health and functioning in patients with axial spondyloarthritis: results from the reumavid study (phase 1) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Impact of the Covid-19 pandemic and lockdown on wellbeing on patients with rheumatic diseases. Results from the reumavid study (phase 1) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Non-rheumatologists find it difficult to identify axial spondyloarthritis in women and young people. Results from the spanish atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Patient journey with axial spondyloarthritis: critical issues from the patient perspective. Results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Patient-reported impact of axial spondyloarthritis on working life. Results from the spanish atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Presence and associated factors of fatigue in patients in patients with axial spondyloarthritis. Results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Prevalence and associated factors of sleep disorders in patients with axial spondyloarthritis. Results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | Prevalence and associated factors of sleep disorders in patients with axial spondyloarthritis. Results from the spanish atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | The fracture prevention unit of the Virgen Macarena Hospital reduces the gap in the management of op, particularly in males and meets iof/esceo quality standards | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | The impact of axial spondyloarthritis on patients' sexual life: results from the spanish atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2021 | The importance of physical activity in relation to being overweight/obese with axial spondyloarthritis. Results from the spanish atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | A benchmarking study evaluating the burden of axial spondyloarthritis in Spain compared with the rest of European countries. results of the spanish atlas and emas studies. | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Analysis of adults patients with nod2-associated autoinflammatory disease | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | ASSOCIATION BETWEEN GEOGRAPHIC AND CLIMATOLOGICAL CONDITIONS AND CUTANEOUS MANIFESTATIONS IN LUPUS PATIENTS FROM THE SPANISH RHEUMATOLOGY SOCIETY LUPUS REGISTRY (RELESSER) AND ARGENTINE RHEUMATOLOGY SOCIETY LUPUS REGISTRY (RELESSAR) COHORT | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Characterizing the impact of axial spondyloarthritis on daily life: gender and patient-reported outcomes associated with functional limitation in Canada. Results from the IMAS survey | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Comparative analysis of patient-reported outcomes among employed and unemployed patients with axial spondyloarthritis. results of the spanish atlas 2017 | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Factors associated with use of biological therapies for axial spondyloarthritis in Canada. Results from the IMAS survey. | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Gender differences in patient journey to diagnosis and patient-reported outcomes: results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Identification of parameters associated with a diagnostic delay in axial spondyloarthritis: results from the european map of axial spondyloarthritis (EMAS) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Impact of AXSPA on working life: results from 233 patients of the russian federation participating in the european map of axial spondyloarthirtis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Onset of axial spondyloarthritis repercussions on patients' social and family life: results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Secukinumab provides significant improvement of spinal pain in patients with axial spondyloarthritis: results from the 24-week phase 3 skippain study | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | The economic burden of ankylosing spondylitis in Spain. Results of the Spanish atlas 2017 | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | The impact of axial spondyloarthritis on patients' sexual life: results from the european map of axial spondyloarthritis (emas) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | The path of a patient with axial spondyloarthritis to diagnosis in Russia, data from the EMAS survey | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2020 | Tocilizumab in refractory takayasu arteritis. Open-label national multicenter study of 53 patients of clinical practice | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Adverse autoimmune events in cancer patientstreated with immunotherapy. Analysis of cases between 2011 and 2018 | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Cryopyrin-associated periodic syndrome: a serie of cases in a adult 's patients cohort with autoinflammatory syndrome in a third level hospital | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Experience with the use of rituximab for the treatment of systemic autoimmune diseases (sad) in a tertiary hospital | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 2019 | Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Impact of axial spondyloarthritis on patients' professional life: results from the online survey emas of 638 french patients | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Impact of axial spondyoarthritis (axspa) on social and family life: results of the emas survey of 638 patients in 2018 | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Is obesity a factor of poor outcome in spondyloarthritis? an analysis of 638 patients | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Obesity and associated factors in norwegian axial spondyloarthritis patients. Results from the European map of axial spondyloarthritissurvey | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Patient-reported attitudes towards axial spondyloarthritis: Results from the emas survey | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | Patient-reported impact of axial spondyloarthritis on working life: Results from the emas survey | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2019 | The tnf receptor-associated periodic syndrome (traps): clinical and genetic characterization of a cohort of adults diagnosed of traps syndrome | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2018 | Analysis of B-cells subsets in first degree relatives of patients with systemic lupus erythematosus | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2018 | Autoinflammatory syndromes: clinical and genetic characterisation of a cohort of adult patients in a single reference centre | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2018 | Effect of custom-made foot orthoses versus placebo in patients with rheumatoid arthritis: randomised clinical trial | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2018 | Gender differences in patients with axial spondyloarthritis: results from the atlas-2017 | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2018 | Mental health disorders in patients with axial spondyloarthritis: increasing our understanding of the disease. Results from the atlas-2017 | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2018 | Quality of life improvement in patients with axial spondyloarthritis treated with nsaids and biological therapy from the patient's perspective: results from the atlas-2017 | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2018 | The value of belonging to patients' association for axial spondyloarthritis: results from the atlas-2017 | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2018 | Thoracic involvement at diagnosis drives a differentiated clinical presentation of sarcoidosis: analysis of 1245 patients (sarcogeas-semi) | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2017 | Association between smoking with spinal level of stiffness and functional limitation in patients with axial spondyloarthritis: Results from the Spanish atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2017 | End-stage organ failure in sarcoidosis: characterization and predictive factors in 1082 patients | ANNALS OF THE RHEUMATIC DISEASES |
| Ponencia | 2017 | Exergames versus self-regulated exercises with instruction leaflets to improve adherence in geriatric rehabilitation: a randomized controlled trial | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2017 | Giant cell arteritis: atherosclerosis as pitfall in the halo sign | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2017 | Hopes and fears of patients with Axial Spondyloarthritis in Spain. The value of patient opinion: results from the Spanish Atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2017 | Impact of a training program and early referral on diagnostic delay in patients with axial spondyloarthritis: results from the Spanish atlas | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2017 | Sarcoidosis and cancer: different patterns of association in a multicenter cohort from southern europe | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2017 | Sarcoidosis in Spain: clinical and epidemiological characteristics at diagnosis in 1082 patients | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2017 | Ultrasound in giant cell arteritis: cut-off and pitfalls in the halo sign | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 2016 | Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2016 | Genetic characterization of hereditary periodic fever syndromes: a retrospective cohort of 25 patients | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 2015 | A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2015 | Optimizing treatment with etanercept in patients with rheumatoid arthritis | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2015 | Tocilizumab Compared with Anakinra in Refractory Adult-Onset Still's Disease. Multicenter Study of 75 Patients | ANNALS OF THE RHEUMATIC DISEASES |
| Ponencia | 2014 | CONSENSUS STATEMENT ON THE MANAGEMENT OF PREOPERATIVE PAIN IN PATIENTS WITH TOTAL KNEE AND/OR HIP REPLACEMENT | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2014 | Efficacy of anakinra in refractory adult-onset still's disease: multicenter open-label study of 34 patients | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2013 | Hospitalization of individuals with spondyloarthritis and biologic treatment: an analysis of 139 patients | ANNALS OF THE RHEUMATIC DISEASES |
| Ponencia | 2013 | PSYCHOMETRIC CHARACTERISTICS OF A SPANISH TRANSLATION OF THE MANCHESTER FOOT PAIN AND DISABILITY INDEX: VALIDATION AND RASCH ANALYSIS | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2013 | Relationship between anticitrullinated protein antibodies and clinical remission in arthritis | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2013 | Switching infliximab for new alternatives: a correspondence analysis of biologics, reasons to stop, and time periods | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2013 | Values of B lymphocyte subpopulations (healthy population) using flow cytometry a starting point for any study | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2011 | Impact of two biological treatments in the functional capacity of a cohort of patients with rheumatoid arthritis | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2011 | Interstitial lung disease in patients with scleroderma: treatment with rituximab | ANNALS OF THE RHEUMATIC DISEASES |
| Resumen congreso | 2011 | Study on autoimmune mechanisms in the neurological process | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 2007 | All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 2007 | Asporin repeat polymorphism in rheumatoid arthritis | ANNALS OF THE RHEUMATIC DISEASES |
| Letter | 2002 | Rheumatic pneumonia [8] (multiple letters) | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 2001 | Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease | ANNALS OF THE RHEUMATIC DISEASES |
| Letter | 2001 | Rheumatic pneumonia [8] | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 1996 | Antimyeloperoxidase antibodies in individuals with occupational exposure to silica | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 1995 | TAP POLYMORPHISM IN PATIENTS WITH BEHCETS-DISEASE | ANNALS OF THE RHEUMATIC DISEASES |
| Letter | 1994 | SILICON NEPHROPATHY AND MYELOPEROXIDASE ANTIBODIES - REPLY | ANNALS OF THE RHEUMATIC DISEASES |
| Artículo | 1993 | MULTIPLE CLINICAL AND BIOLOGICAL AUTOIMMUNE MANIFESTATIONS IN 50 WORKERS AFTER OCCUPATIONAL EXPOSURE TO SILICA | ANNALS OF THE RHEUMATIC DISEASES |
